首页 正文

Diagnostic Value of Serum Fibroblast Growth Factor 21 Combined with Fibrosis-4 Index for Hepatic Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease

{{output}}
Background/aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease, with significant fibrosis (≥F2) strongly associated with adverse outcomes. The current study evaluate... ...